Dissolution and bioavailability enhancement of carbamazepine

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue SUPPL.1, 2013, Pages 395-400

  Hardikar, Sharwaree R ^a   Bhosale, Ashok V ^a   Chonkar, Ankita D ^a   Saindane, Rupesh A ^a  

^a PDEA's Seth Govind Raghunath Sable College of Pharmacy   (India)

Author keywords

Carbamazepine; Dried Mucilage; Gel; Ocimum basilicum; Solid dispersion

Indexed keywords

CARBAMAZEPINE; OCIMUM BASILICUM EXTRACT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; INFRARED SPECTROSCOPY; MALE; MUCILAGE; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; ZETA POTENTIAL;

EID: 84875447063     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Pattewar S. V.: Solubility enhancement of poorly aqueous soluble drug-Simvastatin by using HPMCE3LV. International Journal of Pharmacy and Pharmaceutical Sciences. 2012; 4: 498-502.
2. Vasanthvata M., W. Q. Tong, Y. Joshi, S. Kislalioglu: Phase behavior of amorphous molecular dispersions I: Determination of the degree and mechanism of solid solubility. Pharmaceutical Research. 2004; 21: 1598-1606.
3. P. Costa, T. Vasconcelos, B. Sarmento: Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today. 2007; 12: 1068-1074.
4. I Dressman, C. Leuner, Improving drug solubility for oral delivery using solid dispersions: European Journal of Pharmaceutics and Biopharmaceutics. 2000; 50: 47-60.
5. Y. Rane, R. Mashru, M. Sankaliya, J. Sankaliya: Effect of Hydrophillic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology. AAPS PharmSciTech. 2008; 8: E1-E11.
6. G. Betz, S. Šehić, Š. Hadžidedić, S. Kocova, El-Arini, H. Leuenberger: Investigation of intrinsic dissolution behavior of different carbamazepine samples. International Journal of Pharmaceutics. 2010; 186: 77-90.
7. G. Betz, F. Flicker, V. A. Eberle: Variability in commercial carbamazepine samples-Impact on drug release. International Journal of Pharmaceutics. 2011; 410: 90-108.
8. G. Gambereni C Rustichelli, V Ferioli, M. C Gamberini, R Ficarra, S Tommasini: Solid state study of polymorphic drugs: Carbamazepine. Journal of Pharmaceutical and Biomedical Analysis. 2000; 23: 41-54.
9. S W Hoag, R Nair, S Gonen: Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of Carbamazepine. International Journal of Pharmaceutics. 2002; 240: 11-22.
10. D. Murphy, F. Rodríguez-Cintrón, B. Langevin, R. C. Kelly, N. Rodríguez-Hornedo: Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. International Journal of Pharmaceutics. 246; 2002: 121-134.
11. N. Sandler, F. Tian, K. C. Gordon, C. M. McGoverin, A. Reay, C. J. Strachan, D. J. Saville, T. Rades: Visualizing the conversion of carbamazepine in aqueous suspension with and without the presence of excipients: A single crystal study using SEM and Raman spectroscopy. European Journal of Pharmaceutics and Biopharmaceutics. 64; 2006: 326-335.
12. S. Hardikar, A. Bhosale, N. Jamdade: A concept proof of potential of experimental dried mucilage isolated from the seeds of Ocimum basilicum as a disintegrant. International Journal of Pharmacy and Pharmaceutical Sciences. 2012; 4: 692-695.
13. G. Szakonyi, R. Zelko: Water content determination of superdisintegrants by means of ATR-FTIR spectroscopy. Journal of Pharmaceutical and Biomedical analysis. 2012; 63: 106-111.
14. C. Sammon, G. Bajwa, P. Timmins, C. D. Melia: The application of attenuated total reflectance Fourier transform infrared spectroscopy to monitor the concentration and state of water in solutions of a thermally responsive cellulose ether during gelation. Polymer. 2006; 47: 577-584.
15. Bhosale, S. Hardikar, H. Sable, A. Pathak: Investigation of hydrogel isolated from the seeds of Ocimum basilicum as a binder. Indian Journal of Pharmaceutical Sciences. 2009; 71: 320-322.
16. Sugimoto M, Okagaki T, Narisawa S, Koida Y, Nakajima K: Improvement of dissolution characteristics and bioavailability of poorly water-soluble drug by novel co grinding method using water-soluble polymer. International Journal of Pharmaceutics. 1998; 160; 11-19.
17. ICH, ICH Q8 A(R2), Stability testing of new drug substances and products (February 2003), 2003, http: //www. ich. org
18. L. A. P. Freitas, R. M. Martins, S. Siqueira, L. A. Tacon: Microstructured ternary solid dispersions to improve carbamazepine solubility. Powder Technology. 2012; 215-216: 156-165.
19. Indian Pharmacopoeia, Government of India, Ministry of Health and Family Welfare, I, Published by the controller of Publications, Delhi, 1996, pp. 137.
20. Khan K. A,: The concept of dissolution efficiency. Journal of Pharmacy and Pharmacology. 1975; 27: 48-49.
21. Guidance for Industry, Bioanalytical Method Validation, U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Rockville, MD, May, 2001.
22. S. B. Bhise, M. Rajkumar,: Effect of HPMC on solubility and dissolution of carbamazepine form III in simulated gastrointestinal fluids. Asian Journal of Pharmaceutics. 2008; 2: 38-42.
23. R. J. Behme, D. Brook,: Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple phase changes during differential scanning calorimetry analysis. Journal of Pharmaceutical Sciences. 1991; 80: 986-990.
24. M. Schuleit, C. Dahlberg, A. M. Fureby,: Surface composition and contact angle relationships of differently prepared solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics. 2008; 70: 478-485.
25. J. Salonen M. Kaasalainen, E. Mäkilä, J. Riikonen, M. Kovalainen, K. Järvinen, K.-H. Herzig, V.-P. Lehto,: Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations. International Journal of Pharmaceutics. 2012; 431: 230-236.
26. L. Wu, J Zhang, W. Watanabe,: Physical and chemical stability of drug nanoparticles. Advanced drug delivery reviews. 2011; 63: 456-469.
27. V. A. Saharan, V. Kukkar, M. Kataria, M. Gera, P. K. Chaudhary,: Dissolution Enhancement of Drugs. Part I: Technologies and Effect of Carriers. International Journal of Health Research. 2009; 2: 107-124.
28. M. Otsuka, Y. Hattori, Y. Haruna,: Dissolution process analysis using model-free Noyes-Whitney integral equation. Colloids and Surfaces B: Biointerfaces. 2013; 102: 227-231.